People | September 19, 2023
Biocon names Peter Bains as Group CEO
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
The Government of India continues to prioritise initiatives aimed at enhancing the accessibility and equity of health services
Approval of this product under the PEPFAR program completes Strides’ qualification to all major markets and donor programs including Global Fund and South Africa
Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
The product is expected to start contributing meaningfully to the revenue from FY25
The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
,_HQ_and_T7_RNA_polymerase,_HQ__From_left_to_right_256_384.jpg)
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
Subscribe To Our Newsletter & Stay Updated
